Last €3.44 EUR
Change Today -0.045 / -1.29%
Volume 21.7K
As of 11:35 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce A. J. Ponder Ph.D., FRCP,FRCPath,FMedSci,FRS

Former Chairman of Scientific Advisory Board, MDxHealth SA
AgeTotal Calculated CompensationThis person is connected to 23 board members in 3 different organizations across 3 different industries.

See Board Relationships
70--

Background*

Sir Bruce A. J. Ponder, Ph.D., FRCP,FRCPath,FMedSci,FRS, serves as a Scientific Advisor at KuDOS Pharmaceuticals Limited. He is a Co-Director at the Hutchison/MRC Research Institute. Sir Ponder is the Founding Director at the new Cambridge University (Hutchison) Cancer Research U.K. Institute. He also consults for Hutchison/ companies. He was a Co-Director at Strangeways Research Laboratories. Sir Ponder is honorary Consultant Physician at Addenbrooke's Hospital. He ...

Read Full Background

Corporate Headquarters*

CAP Business Center
Herstal, Liège 4040

Belgium

Phone: 32 4 364 20 70
Fax: 32 4 364 20 71

Board Members Memberships*

2000-Present
Non Executive Director, Member of Management Engagement Committee and Member of Nomination Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXH:BB €3.44 EUR -0.045

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James T. LaFrance Chairman, Chief Executive Officer and President
Vermillion, Inc.
--
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Howard B. Doran Jr.Chief Executive Officer, President and Director
LipoScience, Inc.
--
Kevin Kowbell Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$247.9K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MDXHEALTH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.